Literature DB >> 4620298

A controlled clinical trial of small daily doses of rifampicin in the prevention of adverse reactions to the drug in a once-weekly regimen of chemotherapy in Hong Kong: second report:-the results at 12 months.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4620298     DOI: 10.1016/0041-3879(74)90046-4

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


× No keyword cloud information.
  2 in total

Review 1.  Recurrent disseminated intravascular coagulation caused by intermittent dosing of rifampin.

Authors:  Thomas C Havey; Christine Cserti-Gazdewich; Michelle Sholzberg; Jay S Keystone; Wayne L Gold
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

2.  Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study.

Authors:  Timothy R Sterling; Ruth N Moro; Andrey S Borisov; Elizabeth Phillips; Gillian Shepherd; Newton Franklin Adkinson; Stephen Weis; Christine Ho; Margarita Elsa Villarino
Journal:  Clin Infect Dis       Date:  2015-04-22       Impact factor: 9.079

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.